Teleflex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Teleflex and other ETFs, options, and stocks.

About TFX

Teleflex, Inc. engages in the provision of medical technology products. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia Pacific. 

CEO
Jason Weidman
CEOJason Weidman
Employees
15,500
Employees15,500
Headquarters
Wayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded
1943
Founded1943
Employees
15,500
Employees15,500

TFX Key Statistics

Market cap
5.26B
Market cap5.26B
Price-Earnings ratio
-5.34
Price-Earnings ratio-5.34
Dividend yield
1.08%
Dividend yield1.08%
Average volume
678.42K
Average volume678.42K
High today
$126.56
High today$126.56
Low today
$123.05
Low today$123.05
Open price
$126.36
Open price$126.36
Volume
546.05K
Volume546.05K
52 Week high
$145.00
52 Week high$145.00
52 Week low
$100.18
52 Week low$100.18

Stock Snapshot

Teleflex(TFX) stock is priced at $124.44, giving the company a market capitalization of 5.26B. It carries a P/E multiple of -5.34 and pays a dividend yield of 1.08%.

During the trading session on 2026-10-13, Teleflex(TFX) shares reached a daily high of $126.56 and a low of $123.05. At a current price of $124.44, the stock is +1.1% higher than the low and still -1.7% under the high.

Trading activity shows a volume of 546.05K, compared to an average daily volume of 678.42K.

Over the past 52 weeks, Teleflex(TFX) stock has traded between a high of $145.00 and a low of $100.18.

Over the past 52 weeks, Teleflex(TFX) stock has traded between a high of $145.00 and a low of $100.18.

TFX News

MarketWatch 6h
Teleflex Inc. stock outperforms competitors despite losses on the day - MarketWatch

...

Teleflex Inc. stock outperforms competitors despite losses on the day - MarketWatch
Simply Wall St 2d
Teleflex, What Is Drawing Fresh Attention To The Stock?

Teleflex (TFX) is back in focus after publishing new peer reviewed data in the American Journal of Infection Control. The study links its Arrowg+ard catheter te...

Teleflex, What Is Drawing Fresh Attention To The Stock?
TipRanks 2d
Teleflex completes patient enrollment in BIOMAG-LL Clinical Study

Teleflex (TFX) Iannounced the successful completion of patient enrollment in the BIOMAG-LL Clinical Study, evaluating the safety and clinical performance of the...

Analyst ratings

63%

of 16 ratings
Buy
37.5%
Hold
62.5%
Sell
0%

More TFX News

Simply Wall St 7d
Learn Why The Bull Case For Teleflex Could Change Following Infection Study Results

Teleflex reported that a peer reviewed American Journal of Infection Control study of 1,750 ICU patients found Arrowg+ard Technology central venous catheters we...

Learn Why The Bull Case For Teleflex Could Change Following Infection Study Results

People also own

Based on the portfolios of people who own TFX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.